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Bartonella species are hematotropic bacteria
that have been isolated from humans, cats, dogs,
wildlife species, rodents, and arthropods. The
mammalian reservoir for B. clarridgeiae and B.
henselae is the domestic cat, in which asymptom-
atic infection can be maintained for long periods
(1–3). Feline infection with B. henselae is
widespread throughout the world, and B.
clarridgeiae has been isolated from cats in
Europe and various regions of the United States
(4–6). Chomel et al. have demonstrated flea
transmission of B. henselae between cats (7).
Prolonged bacteremia has been demonstrated in
cats, but to our knowledge persistent asymptom-
atic B. vinsonii subsp. berkhoffii infection in dogs,
as described in this report, has not been
previously documented. Human exposure to B.
henselae can result in cat-scratch disease (CSD)
or other medical conditions (8), and B.
clarridgeiae was recently implicated as the cause
of CSD in a veterinarian (6).
B. vinsonii was originally isolated by Baker in
1946; splenic homogenates were cultured from
voles that inhabited a former immigrant quaran-
tine station on Grosse Isle, Canada (9). No other
isolates of B. vinsonii were described until 1995
when we recovered a similar organism from a dog
with valvular endocarditis (10). Subsequent
genotypic evaluation of the vole and canine
isolates resulted in taxonomic division of the
species into subspecies. The vole and canine isolates
were designated B. vinsonii subsp. vinsonii and B.
vinsonii subsp. berkhoffii, respectively (11).
Although the type strain of B. vinsonii subsp.
berkhoffii was isolated from a dog with cardiac
disease, the organism can also cause subclinical
infection. The reservoir for B. vinsonii subsp.
berkhoffii has not been established, but
seroepidemiologic evidence supports the poten-
tial for tick transmission (12).
We describe infection of three pets within the
same household with three different Bartonella
species and the subclinical persistence of B. vinsonii
subsp. berkhoffii infection in a dog for 14 months.
This report is a component of other ongoing
studies of Bartonella infection in animals. In
conjunction with an earlier study, a veterinary
student offered her cats as controls for an
investigation into the prevalence of B. henselae
associated with cases of CSD (1). Three cats and
the dog were subsequently monitored for
bacteremia and seroreactivity during a bartonella
antimicrobial efficacy study, in which the cats
received 22.7 mg enrofloxacin q12h PO for 28
days and the dog received 25 mg doxycycline q12h
PO for 28 days (13).
Blood samples were collected from the dog
and additional cats acquired later by the student.
At each collection, all animals were assessed for
general health. For the dog, packed cell volume
and total plasma protein were determined from
EDTA blood samples.
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We monitored by blood culture and immunofluorescence assay (IFA) bartonella
infection in one dog and eight cats in a household to determine the prevalence and
persistence of the infection as well as its transmissibility to humans. Ectoparasite control was
rigorously exercised. During a 3-year period, Bartonella clarridgeiae was recovered from one
cat on two occasions, and B. henselae was isolated from another cat on four occasions.
During a 16-month period, B. vinsonii subsp. berkhoffii was isolated from the dog on 8 of 10
culture attempts. Despite extensive household contact, the pet owner was seronegative to
all three species by IFA for Bartonella-specific immunoglobulin G.326 Emerging Infectious Diseases Vol. 4, No. 2, April–June 1998
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Sera were analyzed by immunofluorescence
antibody assay (IFA) for reactivity against B.
clarridgeiae, B. henselae, and B. vinsonii subsp.
berkhoffii (1). All positive serum samples (dog,
cat, and human) were reassayed at least three
separate times.
Blood samples from the dog and cats were
placed into 1.5-ml pediatric isolator tubes
(Wampole Laboratories, Cranbury, NJ) for
Bartonella culture on rabbit blood agar (1).
Isolates were identified by polymerase chain
reaction-restriction fragment length polymor-
phism (PCR-RFLP) analysis of the 16S rRNA
gene and 16S-23S intergenic spacer (ITS) region
using Dde I, Mnl I, Hae III, and Alu I restriction
endonuclease (6). DNA from the type strains of B.
clarridgeiae (ATCC 51734), B. henselae (ATCC
49882), and B. vinsonii subsp. berkhoffii (ATCC
51672), in addition to B. vinsonii subsp. berkhoffii
strains cultured from two healthy dogs, was
analyzed for comparison.
The dog, cats, and pet owner remained
healthy throughout the study. The packed cell
volume and total plasma protein values of the dog
remained within reference ranges. These values
were not routinely assessed in the cats. The
source, age, and order of introduction of animals
into the household are depicted in Table 1.
Bartonella-specific immunoglobulin G (IgG) was
detected at various titers in the animals (Table 2).
During the 3-year period (December 1993 to
January 1997), B. clarridgeiae was recovered
from one cat on two occasions, and B. henselae
was isolated from another cat on four occasions.
B. vinsonii subsp. berkhoffii was isolated from
Table 1. Animals included in the study
Animal Breeda Sexb Birth- Date Source/
date acquired state
Cats
A DSH M/C 10/91 12/91 Pet store/CA
B DSH F/S 10/90 12/90 Stray/DE
C DLH F/S   6/92   6/92 Stray/NC
D DSH M/C   4/93   5/93 Stray/NC
E DSH F/S   5/93   7/93 Stray/NC
F DLH M/C   4/94   6/94 Stray/NC
G DLH F/S   6/95 10/95 Stray/NC
H MC M/C   6/96   9/96 Family/NC
Dog
I PM F/S   4/95   6/95 Family/NC
aDSH, Domestic shorthair; DLH, Domestic longhair; MC,
Maine coon; PM, Pekingese mix.
bM/C, Male/castrated; F/S, Female/spayed.
Table 2. Blood culture and immunofluorescence antibody
assay results
Culture Colony Serologic results
Date ID resultsa counts/ml Bh Bc Bvb
12/4/93 A + (Bh)       97 256    32 512
D– N D b   ND  ND
1/15/94 C + (Bc)       67 <16  <16 <16
5/25/94 A + (Bh)       13 128    16 256
C + (Bc)     113 128  <16 <16
D – 256 1024 512
8/19/94 A cont 128  <16 128
C + (Bc)     240   64  <16 <16
9/18/94 F nd <16  <16 <16
12/9/94c A –   32  <16 128
12/13/94 C –   32  <16   64
D – 128 1024 512
5/6/95d A –   64 <16   64
C + (Bc)        9   32 <16   32
F – <16 <16 <16
5/27/95 A –   64   16   64
C – <16 <16 <16
F – <16 <16 <16
6/10/95 A –   32 <16   64
C –   32 <16 <16
F – <16 <16 <16
6/22/95 A –   32 <16 128
C – <16 <16   32
F – <16 <16 <16
7/30/95 A –   32 <16 256
C –   32 <16 <16
F – <16 <16 <16
11/19/95 A –   16 <16 256
B – <16 <16   32
C –   32 <16   32
D –   64 <16   64
E – <16 <16 256
F – <16 <16   32
G –   32 <16 128
I + (Bvb) >1000 128 <16 512
2/25/96 I + (Bvb)     369   64 <16 256
3/24/96 I + (Bvb)     164   32 <16 256
4/21/96 I + (Bvb)     154   16 <16 128
6/22/96 I + (Bvb)     357   16 <16 128
8/24/96 I + (Bvb)       12 <16 <16   64
10/21/96 I – <16 <16   64
12/18/96 I + (Bvb)         6   16 <16   64
1/22/97 student     nd   32   16   32
1/14/97 A –   16 <16 128
B – <16 <16 <16
C – <16 <16   16
D –   64 <16   64
G – <16 <16   32
H –   64 <16 256
1/30/97e I + (Bvb)         1   16 <16   64
3/21/97 I –   16 <16   32
aBh, B. henselae; Bc, B. clarridgeiae; Bvb, B. vinsonii subsp.
berkhoffii; cont, contaminated; nd, not done.
bND, no data.
cFour weeks before sample was drawn, the cat received
amoxicillin clavulanate (62.5 mg q12h, for 10 days) for the
treatment of an oral abscess.
dAfter collection of blood samples, these animals received
enrofloxacin at 22.7 mg q12h for 28 days.
eAfter collection of blood samples, the dog received 28 days of
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the dog on 8 of 10 culture attempts during 16
months of observation (Table 2). Only one
species of Bartonella was identified from any
individual animal. In all three animals, blood
cultures performed after completion of antimi-
crobial therapy were negative.
When compared with type strains, PCR-
RFLP analysis of the 16S rRNA gene and the
16S-23S ITS region identified the feline isolates
as B. clarridgeiae or B. henselae. Endonuclease
digestion of the 16S gene of the isolates from the
dog as well as two isolates from other subclinically
bacteremic dogs produced restriction patterns
identical to the type strain of B. vinsonii subsp.
berkhoffii; however, digestion of the ITS region
resulted in a different restriction profile for the
subclinically bacteremic dogs (Figure).
We did not detect bacteremia temporally
associated with exposure to known bacteremic
animals in any pet newly introduced to the
household. Chomel et al. (7) reported that as few
as five infected fleas could transmit B. henselae
infection between cats, but normal daily contact
between infected and uninfected cats in
ectoparasite-free surroundings was insufficient
to produce bacteremia in the uninfected cats.
Despite their immunologic status (seronegative)
and the occasional presence of fleas, some cats in
this household did not seroconvert or become
bacteremic after continued exposure to infected
resident animals. Although we have observed
that infection with B. henselae is not cross-
protective against B. clarridgeiae (Kordick and
Breitschwerdt, unpub. data) and that dual
infection with B. clarridgeiae and B. henselae
can occur in cats (2,6), similar data are not
available with regard to B. vinsonii subsp.
berkhoffii.  B. vinsonii subsp. berkhoffii bacter-
emia has not been reported in cats. Intradermal
injection of B. henselae into dogs has induced
seroconversion but not bacteremia (14). It is
therefore not surprising that B. vinsonii subsp.
berkhoffii was not recovered from any of the cats
in the study or, conversely, that B. henselae or B.
clarridgeiae were not recovered from the dog.
Interpretation of Bartonella IFA serologic
results for species identification has been
compromised because of presumed cross-reactiv-
ity. The dog in this study never seroconverted to
B. clarridgeiae or B. henselae; however, the cat
infected with B. henselae had a consistently
elevated level of antibodies reactive against
B. vinsonii subsp. berkhoffii antigen. The issue
Figure. A. Polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP) analysis of
the 16S rRNA gene of B. vinsonii subsp. berkhoffii
isolates using Dde I demonstrating differentiation
between subspecies of B. vinsonii. B. PCR-RFLP
analysis of the 16S-23S intergenic spacer region of B.
vinsonii subsp. berkhoffii isolates using Hae III. Strain
differences were detected between B. vinsonii subsp.
berkhoffii (T), which was the type strain cultured from a
dog with endocarditis, and isolates A (described in this
report), B, and C from subclinically infected dogs.
A
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of serologic cross-reactivity among Bartonella
species deserves additional study.
Subtyping of bacteria after endonuclease
digestion of the 16S-23S rRNA ITS region has
been performed by other investigators because
the spacer region, not appearing to encode
functional proteins, demonstrates sequence
variability in an operon that has been useful for
taxonomic classification (15,16). In this study,
different restriction profiles were obtained from
isolates derived from asymptomatic dogs com-
pared with the type strain obtained from a dog
with endocarditis. Since our sample size was
small, further examination of these isolates by
pulsed-field gel electrophoresis or bacteriophage
analysis may determine whether PCR-RFLP
analysis is epidemiologically useful in predicting
the pathogenicity of different strains.
The pet owner (student) remained healthy
throughout the study; however, she reported that
2½ years before the study she had debilitating
fatigue of 1 month duration without fever or
lymphadenopathy. At the time, she lived in
California and had recently acquired Cat A. A
mononucleosis test was negative; her physician
suspected a viral infection. Whether the fatigue
was related to Bartonella exposure (CSD) or the
cat was bacteremic is not possible to determine
retrospectively; however, the cat was bacteremic
with B. henselae when cultured 2½ years later as
part of another study (1). Bartonella transmis-
sion from dogs and cats to humans appears to be
relatively inefficient. It is not surprising, therefore,
that despite continuous exposure to three
Bartonella species, the student’s serum sample was
minimally reactive to Bartonella antigens.
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